A U.S. study found that patients who received combined hormone replacement therapy for about five years are more likely to have abnormal mammograms and breast biopsies compared with those who received a placebo. The findings suggest that HRT may affect the efficacy of the tests in breast cancer diagnosis. A doctor said women need to be more aware of the risks involved in HRT.

Full Story:

Related Summaries